What is Imagenetix, Inc. (IAGX)?

Imagenetix, Inc. (IAGX) is a stock in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. View full analysis on Stocks360.

What is the current price of IAGX?

The current price of IAGX is $0.00. Prices are updated in real time on Stocks360.

What is IAGX's price-to-earnings (PE) ratio?

IAGX's trailing twelve-month PE ratio is -0.13, based on current price and earnings per share data available on Stocks360.

What is IAGX's market capitalization?

IAGX's market capitalization is $2,842.00, placing it in the small-cap tier.

Imagenetix, Inc. (IAGX)

Stock analysis · OTC · Healthcare · Drug Manufacturers - Specialty & Generic

$0.00

Market Cap

$2.84K

PE (TTM)

-0.13

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

0.66

Day Range

$0.00 – $0.00

52-wk Range

$0.00 – $0.00

Avg Volume

N/A

Volume

1.00K

Imagenetix, Inc. (IAGX) is a publicly traded company in the Healthcare sector. Latest price: $0.00. Market cap $2.84K. Trailing PE -0.13. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-29 · $0.00 2026-10-27 · $0.00 (+0.00%)

Proprietary Signals

Signal snapshot temporarily unavailable.

About Imagenetix, Inc.

Established in 1996 and headquartered in San Diego, California, Imagenetix, Inc. focuses on the creation, manufacturing, and distribution of distinctive, natural-ingredient nutritional supplements, as well as non-prescription topical creams and skincare solutions. Its flagship product, Celadrin, is a specialized formulation aimed at promoting joint well-being. The company also extends its business by licensing its proprietary technologies to third parties. Imagenetix reaches its customer base through a wide range of marketing avenues, encompassing direct and large-scale marketing enterprises, health and nutritional periodicals, medical and wellness professionals, and direct-response campaigns across radio and television.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-0.13×
P/S (TTM)	0.00×
P/B	0.00×
P/FCF (TTM)	-0.00×
EV / EBITDA	-3.36×
EV / Sales	-0.07×
Earnings Yield	-766.02%
Free Cash Flow Yield	-25229.42%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	-$60.60K
Net Income (TTM)	-$21.77K
Free Cash Flow (TTM)	-$681.21K
Net Debt	-$63.44K
Working Capital	-$267.68K
Gross Margin	41.59%
Operating Margin	1.74%
Net Margin	-2.63%
Return on Equity	-3.39%
Return on Invested Capital	0.17%